Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Screener
News
About

LMAT - LeMaitre Vascular, Inc. Latest News | Finranks

Home

/

LMAT

L

LeMaitre Vascular, Inc. (LMAT)

NGM – Real Time Price. Currency in USD

97.22

-4.42 (-4.35%)

At close: May 12, 2026, 4:00 PM EDT

97.22

0.00 (0.00%)

After-hours: May 12, 2026, 4:10 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

LeMaitre to Present at the Bank of America Healthcare Conference

LeMaitre to Present at the Bank of America Healthcare Conference

BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that management will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026, at 5:15 PM PT.

3 Reasons Growth Investors Will Love LeMaitre (LMAT)

3 Reasons Growth Investors Will Love LeMaitre (LMAT)

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

LeMaitre (LMAT) Upgraded to Buy: Here's Why

LeMaitre (LMAT) Upgraded to Buy: Here's Why

LeMaitre (LMAT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

LeMaitre Vascular, Inc. (LMAT) Q1 2026 Earnings Call Transcript

LeMaitre Vascular, Inc. (LMAT) Q1 2026 Earnings Call Transcript

LeMaitre Vascular, Inc. (LMAT) Q1 2026 Earnings Call Transcript

LeMaitre Vascular (LMAT) Tops Q1 Earnings Estimates

LeMaitre Vascular (LMAT) Tops Q1 Earnings Estimates

LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.68 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $0.48 per share a year ago.

LeMaitre Q1 2026 Financial Results

LeMaitre Q1 2026 Financial Results

BURLINGTON, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q1 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance.

Q1 2026 In Review - March Dividend Income Report

Q1 2026 In Review - March Dividend Income Report

After 3 months in 2026, I heard more noise than quality information. Therefore, I don't intend to make any modifications to my portfolio at this point. Dollarama reported a mixed quarter with revenue up 12%, but EPS was up only 2%. That sent the stock price down and created the temptation to invest a little more in this amazing company. I'm accumulating more dividends in this portfolio, and I'll shortly have another $1,000 to invest! I will likely add more of Broadcom as I'm not yet fully invested at 3% of the portfolio in this security.

Videos

Final Trade: LMAT, REGN, BA, TJX

Press releases

LeMaitre Q1 2026 Financial Results

LeMaitre Q1 2026 Financial Results

BURLINGTON, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q1 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance.

LeMaitre Q4 2025 Financial Results

25.02.2026

LeMaitre Q4 2025 Financial Results

BURLINGTON, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q4 2025 results, announced a quarterly dividend of $0.25/share (+25%), and provided guidance.

LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026

LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026

BURLINGTON, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2025 financial results on Wednesday, February 25, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook.

LeMaitre Q3 2025 Financial Results

LeMaitre Q3 2025 Financial Results

BURLINGTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q3 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance.